You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VAY736

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

Rheumatoid Arthritis Trial in Berlin, Amman (ianalumab)

Active, not recruiting
  • Rheumatoid Arthritis
  • ianalumab
  • Berlin, Germany
  • +1 more
Oct 14, 2022

Sjogren Syndrome Trial (VAY736, Placebo)

Not yet recruiting
  • Sjogren Syndrome
  • VAY736
  • Placebo
  • (no location specified)
Jul 14, 2022

Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • +2 more
  • Singapore, Singapore
    Novartis Investigative Site
Jan 17, 2023

Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Singapore (Ianalumab, Placebo)

Recruiting
  • Warm Autoimmune Hemolytic Anemia (wAIHA)
  • Ianalumab
  • Placebo
  • Singapore, Singapore
    Novartis Investigative Site
Jan 5, 2023

Sjogren Syndrome Trial (VAY736, Placebo)

Not yet recruiting
  • Sjogren Syndrome
  • VAY736
  • Placebo
  • (no location specified)
Jul 14, 2022

Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • Ianalumab
  • +2 more
  • Singapore, Singapore
    Novartis Investigative Site
Jan 23, 2023

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in

Recruiting
  • Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
  • Columbus, Ohio
  • +9 more
Aug 1, 2022

Idiopathic Pulmonary Fibrosis Trial in Worldwide (VAY736, Placebo, Standard of Care (SoC))

Completed
  • Idiopathic Pulmonary Fibrosis
  • VAY736
  • +2 more
  • Birmingham, Alabama
  • +15 more
Sep 6, 2022

Systemic Lupus Erythematosus Trial (Placebo, Ianalumab)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • (no location specified)
Nov 15, 2023

Sjogrens Syndrome Trial (Ianalumab (VAY736), Placebo)

Not yet recruiting
  • Sjogrens Syndrome
  • Ianalumab (VAY736)
  • Placebo
  • (no location specified)
Aug 3, 2023

Primary Sjögren's Syndrome Trial in Berlin (VAY736, Placebo)

Completed
Has Results
  • Primary Sjögren's Syndrome
  • VAY736
  • Placebo
  • Berlin, Germany
    Novartis Investigative Site
Sep 30, 2021

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (VAY736, VAY736 Placebo, CFZ533)

Active, not recruiting
  • Systemic Lupus Erythematosus (SLE)
  • VAY736
  • +3 more
  • Ciudad Autonoma de Bs As, Buenos Aires, Argentina
  • +31 more
Sep 19, 2022

Pemphigus Vulgaris Trial in Worldwide (VAY736, Placebo)

Terminated
Has Results
  • Pemphigus Vulgaris
  • VAY736
  • Placebo
  • Chapel Hill, North Carolina
  • +4 more
Oct 7, 2021

Systemic Lupus Erythematosus Trial (ianalumab, )

Not yet recruiting
  • Systemic Lupus Erythematosus
  • (no location specified)
Nov 21, 2022

Systemic Lupus Erythematosus Trial (Ianalumab, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • (no location specified)
Dec 5, 2022

Rheumatoid Arthritis Trial in Berlin (VAY736, VAY736 )

Completed
  • Rheumatoid Arthritis
  • VAY736
  • VAY736 placebo
  • Berlin, Germany
    Novartis Investigative Site
Dec 9, 2020

Relapse Remitting Multiple Sclerosis Trial in Czechia, Ukraine, United States (VAY736, Placebo)

Terminated
Has Results
  • Relapse Remitting Multiple Sclerosis
  • VAY736
  • Placebo
  • Long Beach, California
  • +4 more
Dec 9, 2020

Primary Sjogren Syndrome Trial in Worldwide (VAY736, Placebo)

Completed
  • Primary Sjogren Syndrome
  • VAY736
  • Placebo
  • Plantation, Florida
  • +55 more
Jan 20, 2022

Lupus Nephritis Trial in Worldwide (ianalumab s.c. q4w, ianalumab s.c. q12w, s.c.)

Recruiting
  • Lupus Nephritis
  • ianalumab s.c. q4w
  • +2 more
  • Fairfax, Virginia
  • +37 more
Oct 14, 2022

Sjogren Syndrome Trial in Brest (Ianalumab)

Recruiting
  • Sjogren Syndrome
  • Ianalumab
  • Brest, France
    Novartis Investigative Site
Jul 28, 2022

Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Trial in Tampa, Barcelona (VAY736)

Terminated
  • Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
  • VAY736
  • Tampa, Florida
  • +1 more
Feb 27, 2018

Primary Sjögren's Syndrome Trial (VAY736 lower dose, VAY736 higher dose)

Withdrawn
  • Primary Sjögren's Syndrome
  • VAY736 lower dose
  • VAY736 higher dose
  • (no location specified)
Apr 19, 2017